Literature DB >> 31232131

First trimester placental volume is reduced in hypertensive disorders of pregnancy associated with small for gestational age fetus.

Tamara Stampalija1, Mariachiara Quadrifoglio1, Daniela Casati2, Sara Zullino2, Valeria Maggi2, Daniela Di Martino3, Eleonora Rosti2, Cristina Mastroianni2, Valentina Signorelli2, Enrico Ferrazzi3.   

Abstract

Introduction: Trophoblastic invasion and placental growth are critical for pregnancy outcome. The placental volume can be assessed by 3 D ultrasound using Virtual Organ Computer-aided Analysis (VOCAL). Epidemiological and clinical data suggest that there are two different clinical phenotypes of hypertensive disorders of pregnancy (HDP) that coexist at any gestational age: HDP associated to fetal growth impairment and HDP associated to appropriate for gestational age fetal growth. The aim of this study was to determine whether placental volume in the first trimester of pregnancy differs between women with HDP associated or not to fetal growth impairment and uncomplicated pregnancies.
Methods: This is a retrospective cross-sectional study of prospectively recruited data in which maternal characteristics, Doppler velocimetry of uterine arteries, and three-dimensional (3 D) volume of the placenta were collected at 11 + 1 - 13 + 6 gestational weeks. The placental quotient (PQ) was calculated as placental volume/crown rump length.
Results: In a 2-year period, we prospectively collected first trimester data of 1322 women. For the purposes of this cross-sectional study, 57 women that delivered a SGA fetus, 34 that developed HDP-AGA, and six that developed HDP-SGA, respectively, were included in the study as cases. The control group was made of 117 uncomplicated pregnancies. The PQ was higher in women with uncomplicated pregnancies (PQ median 16.36 cm3/cm) than in all other study groups (PQ in SGA: 13.02 cm3/cm, p < .001; PQ in HDP-AGA: 12.65 cm3/cm, p = .002; and PQ in women with HDP-SGA: 8.33 cm3/cm [IQR 6.50-10.13], p < .001). The lowest PQ was observed in women with HDP-SGA and was significantly lower than PQ in either women with SGA or those with HDP-AGA (p = .02 and p = .04, respectively). The mean uterine artery pulsatility index was the highest in women with HDP-SGA (median 2.30) compared to all other groups (uncomplicated pregnancies 1.48, p < .0001; women with SGA 1.59, p = .001; and women with HDP-AGA 1.75, p = .009). Discussion: Our findings suggest that HDP associated with SGA is characterized by impaired placental growth and perfusion as soon as in the first trimester of pregnancy. The role of PQ, isolated or in association with other biophysical parameters, to predict HDP with fetal growth impairment remains to be evaluated.

Entities:  

Keywords:  Hypertensive disorders of pregnancy; placental volume; preeclampsia; small for gestational age; uterine artery Doppler

Year:  2019        PMID: 31232131     DOI: 10.1080/14767058.2019.1636026

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  Ultrasound Multiparametric Assessment of the Impact of Hypertensive Disorders of Pregnancy on Fetal Cardiac Function and Growth and Development.

Authors:  Maoting Lv; Shanshan Yu; Yongzhen Li; Xiaoting Zhang; Dan Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-06       Impact factor: 2.650

2.  Fetal biometric and Doppler measurements following abdominal radical trachelectomy in the second trimester of the pregnancy.

Authors:  Eiri Shima; Mina Itsukaichi; Kosuke Yoshihara; Tatsuya Ishiguro; Kazufumi Haino; Koji Nishino; Nobumichi Nishikawa; Koji Nishijima; Takayuki Enomoto
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-20       Impact factor: 3.105

3.  Gestational systolic blood pressure trajectories and risk of adverse maternal and perinatal outcomes in Chinese women.

Authors:  Haoyue Teng; Yumei Wang; Bing Han; Jieyu Liu; Yingying Cao; Jiaxiang Wang; Xiaoyan Zhu; Jiaojiao Fu; Qi Ling; Chengqi Xiao; Zhongxiao Wan; Jieyun Yin
Journal:  BMC Pregnancy Childbirth       Date:  2021-02-22       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.